A rare and mysterious blood disorder has been documented in patients who received the Johnson & Johnson COVID-19 vaccine, raising concerns among medical experts. Cases of thrombotic thrombocytopenic purpura (TTP), a condition involving dangerous blood clots and low platelet counts, have been linked to the vaccine in recent reports. Health authorities are urging those who have received the shot to monitor for symptoms like severe headaches, abdominal pain, or shortness of breath. The connection is still under investigation, but officials emphasize the vaccine’s overall benefits continue to outweigh the risks.